Clinical trials of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) given intravenously in the treatment of malignant melanoma in Uganda. [electronic resource]
Producer: 19720121Description: 143-9 p. digitalISSN:- 0069-0112
- Adult
- Aged
- Antineoplastic Agents -- therapeutic use
- Female
- Head and Neck Neoplasms -- drug therapy
- Humans
- Imidazoles -- administration & dosage
- Injections, Intravenous
- Leukopenia -- chemically induced
- Male
- Melanoma -- drug therapy
- Middle Aged
- Mouth Neoplasms -- drug therapy
- Thigh
- Thrombocytopenia -- chemically induced
- Time Factors
- Uganda
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.